Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.

Journal of hepatology - 1 Feb 2013

Baxa Dwayne M, Thekdi Ashish D, Golembieski Alicia, Krishnan Prashant V, Sharif Omar, Kizy Anne, Shetron-Rama Lynne, Jovanovich John, Chappell Brandi J, Snow-Lampart Andrea, Borroto-Esoda Katyna, Gordon Stuart C

Abstract excerpt

BACKGROUND & AIMS: Reported HBV drug resistance mutations among previously untreated patients with chronic hepatitis B are variable. Whether resistant HBV strains are transmitted in the acute setting is uncertain. We sought to document the presence of antiviral resistance (AVR) mutations in patients with acute HBV (AHB) infection. METHODS: AHB infection was defined by HBsAg/IgM anti-HBc positivity, ALT>10X ULN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Adenine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to Drug Resistance, Viral

Share to Guanine

Share to Hepatitis B

Share to Lamivudine

Share to Organophosphonates

Source

Identifiers

PMID: 23022497
DOI: 10.1016/j.jhep.2012.09.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.PMID 23022497Read ↗

Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.Semantic proximity Read ↗

Hepatitis B virus mutations associated with antiviral therapy.Semantic proximity Read ↗

HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.Semantic proximity Read ↗

[Drug-resistant mutations in hepatitis B virus found in chronic HBV carriers using PCR sequencing technology].Semantic proximity Read ↗

Molecular diagnosis and treatment of drug-resistant hepatitis B virus.Semantic proximity Read ↗

Treatment for hepatitis B in patients with drug resistanceSemantic proximity Read ↗

Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolates.Semantic proximity Read ↗

Antiviral drug resistance and hepatitis B: a continuing public health problem.Semantic proximity Read ↗

Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.Semantic proximity Read ↗

Evaluation of drug resistance mutations in patients with chronic hepatitis BSemantic proximity Read ↗

Comparison of antiviral resistance across acute and chronic viral infections.Semantic proximity Read ↗

Characterization of hepatitis virus B isolated from a multi-drug refractory patient.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.